Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Infectious Diseases and Their Occurrence

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...

Diphtheria

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

Hypersensitivity Reactions: Immune-Complex Reactions

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcomes for clinical trials involving adults with chronic kidney disease: a multinational Delphi survey involving patients, caregivers and health professionals.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2024

Same author

Overcoming barriers to deliver high quality kidney care.

Nature reviews. Nephrology·2024

Same author

Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research.

Canadian journal of kidney health and disease·2024

Same author

Kidney biopsies among persons living in hotspots of CKDu: a position statement from the International Society of Nephrology's Consortium of Collaborators on CKDu.

Kidney international·2023

Same author

Patient and Clinician Experiences With the Combination of Virtual and In-Person Chronic Kidney Disease Care Since the COVID-19 Pandemic.

Canadian journal of kidney health and disease·2023

Same author

Predicting Outcomes in Nephrology: Lots of Tools, Limited Uptake: How Do We Move Forward?

Journal of the American Society of Nephrology : JASN·2023

Search research articles

Related Experiment Video

Updated: Jun 11, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Calciphylaxis in the current era: emerging 'ironic' features?

Myriam Farah¹, Richard I Crawford, Adeera Levin

¹Division of Nephrology, Department of Medicine, St. Paul’s Hospital, University of British Columbia, Vancouver, Canada.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association

|July 15, 2010

Summary

This summary is machine-generated.

Calcific uraemic arteriolopathy (CUA) involves microvascular calcification and tissue necrosis. This study found iron deposition in affected microvasculature, suggesting a role for iron in CUA pathogenesis and potential treatment implications.

Related Experiment Videos

Last Updated: Jun 11, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Area of Science:

Nephrology
Dermatology
Pathology

Background:

Calcific uraemic arteriolopathy (CUA), also known as calciphylaxis, is a rare condition characterized by microvascular calcification, thrombosis, and tissue necrosis.
The exact pathogenesis of CUA is not fully understood, but iron has been proposed as a potential contributing factor.
This study investigates the clinical features of CUA and explores the role of iron in its development.

Purpose of the Study:

To explore the clinical characteristics of patients diagnosed with CUA.
To investigate the potential pathogenic role of iron in CUA development.
To determine if iron deposition is present in microvascular calcification within CUA skin biopsy specimens.

Main Methods:

Retrospective review of 12 CUA patient cases diagnosed between 1997 and 2009.
Dermatopathological analysis of available skin biopsy specimens.
Iron staining of biopsy specimens to detect iron deposition in microvasculature.

Main Results:

Iron deposition was detected in the microvasculature of all analyzed CUA skin biopsy specimens.
Iron was specifically localized to areas of microvascular calcification.
Unaffected microvasculature within the same biopsy specimens did not show iron deposition.

Conclusions:

The presence of iron in affected microvasculature supports its potential role in the pathogenesis of CUA.
Findings suggest implications for iron management in high-risk patients.
The study explores the rationale for using metal chelators, such as sodium thiosulfate, in CUA treatment.